Interventional Oncology Devices | Market Insights | Asia Pacific | 2022
Despite the negative—albeit relatively limited—impact of the ongoing COVID-19 pandemic, the Asia Pacific interventional oncology device market will see strong growth through 2030 driven by a large and rapidly expanding patient pool, improving access to treatment, and the entry of new competitors. However, a lack of reimbursement and pricing pressures will continue to remain a challenge.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for interventional oncology devices in the Asia Pacific region across an 11-year period.
